APO Research
Talk to an analyst

APO RESEARCH · REPORT

Psoriatic Arthritis Therapeutics Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Psoriatic Arthritis Therapeutics Drug Market Analysis and Forecast 2026-2032

30 December 2025195 pages

Choose your research edition.

Industry ResearchPsoriatic Arthritis Therapeutics Drug Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Psoriatic Arthritis Therapeutics Drug Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Psoriatic Arthritis Therapeutics Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Psoriatic Arthritis Therapeutics Drug Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Psoriatic Arthritis Therapeutics Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Psoriatic Arthritis Therapeutics Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Psoriatic Arthritis Therapeutics Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Psoriatic Arthritis Therapeutics Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Psoriatic Arthritis Therapeutics Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Psoriatic Arthritis Therapeutics Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Psoriatic Arthritis Therapeutics Drug include Novartis, Eli Lilly, Pfizer, Amgen, AbbVie, UCB, Janssen Biotech, CELGENE CORPORATION and Bristol-Myers Squibb, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Psoriatic Arthritis Therapeutics Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Psoriatic Arthritis Therapeutics Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Psoriatic Arthritis Therapeutics Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Psoriatic Arthritis Therapeutics Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Psoriatic Arthritis Therapeutics Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Psoriatic Arthritis Therapeutics Drug sales, projected growth trends, production technology, application and end-user industry.

Psoriatic Arthritis Therapeutics Drug Segment by Company

Novartis

Eli Lilly

Pfizer

Amgen

AbbVie

UCB

Janssen Biotech

CELGENE CORPORATION

Bristol-Myers Squibb

Biogen

Psoriatic Arthritis Therapeutics Drug Segment by Type

Interleukin Inhibitors

NF Inhibitors

PDE4 Inhibitors

Others

Psoriatic Arthritis Therapeutics Drug Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Psoriatic Arthritis Therapeutics Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Psoriatic Arthritis Therapeutics Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Psoriatic Arthritis Therapeutics Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Psoriatic Arthritis Therapeutics Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Psoriatic Arthritis Therapeutics Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Psoriatic Arthritis Therapeutics Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Psoriatic Arthritis Therapeutics Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Interleukin Inhibitors Major Manufacturers Table 3. NF Inhibitors Major Manufacturers Table 4. PDE4 Inhibitors Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Retail Pharmacies Major Manufacturers Table 8. Online Pharmacies Major Manufacturers Table 9. Hospital Pharmacies Major Manufacturers Table 10. Psoriatic Arthritis Therapeutics Drug Industry Trends Table 11. Psoriatic Arthritis Therapeutics Drug Industry Drivers Table 12. Psoriatic Arthritis Therapeutics Drug Industry Opportunities and Challenges Table 13. Psoriatic Arthritis Therapeutics Drug Industry Restraints Table 14. Global Psoriatic Arthritis Therapeutics Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Psoriatic Arthritis Therapeutics Drug Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Psoriatic Arthritis Therapeutics Drug Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region (2021-2026) Table 18. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region (2027-2032) Table 19. Global Psoriatic Arthritis Therapeutics Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 20. Global Psoriatic Arthritis Therapeutics Drug Sales by Region (2021-2026) & (W Units) Table 21. Global Psoriatic Arthritis Therapeutics Drug Sales by Region (2027-2032) & (W Units) Table 22. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2021-2026) Table 23. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2027-2032) Table 24. Global Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Psoriatic Arthritis Therapeutics Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Manufacturers (2021-2026) Table 28. Global Psoriatic Arthritis Therapeutics Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Psoriatic Arthritis Therapeutics Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Psoriatic Arthritis Therapeutics Drug Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Psoriatic Arthritis Therapeutics Drug Manufacturers, Product Type & Application Table 32. Global Psoriatic Arthritis Therapeutics Drug Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Psoriatic Arthritis Therapeutics Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Psoriatic Arthritis Therapeutics Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2021-2026) Table 39. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2027-2032) Table 40. Global Psoriatic Arthritis Therapeutics Drug Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 41. Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2021-2026) & (W Units) Table 42. Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2027-2032) & (W Units) Table 43. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2021-2026) Table 44. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2027-2032) Table 45. Global Psoriatic Arthritis Therapeutics Drug Price by Type (2021-2026) & (US$/Unit) Table 46. Global Psoriatic Arthritis Therapeutics Drug Price by Type (2027-2032) & (US$/Unit) Table 47. Global Psoriatic Arthritis Therapeutics Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2021-2026) Table 51. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2027-2032) Table 52. Global Psoriatic Arthritis Therapeutics Drug Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 53. Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2021-2026) & (W Units) Table 54. Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2027-2032) & (W Units) Table 55. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2021-2026) Table 56. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2027-2032) Table 57. Global Psoriatic Arthritis Therapeutics Drug Price by Application (2021-2026) & (US$/Unit) Table 58. Global Psoriatic Arthritis Therapeutics Drug Price by Application (2027-2032) & (US$/Unit) Table 59. Novartis Company Information Table 60. Novartis Business Overview Table 61. Novartis Psoriatic Arthritis Therapeutics Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Novartis Psoriatic Arthritis Therapeutics Drug Product Portfolio Table 63. Novartis Recent Development Table 64. Eli Lilly Company Information Table 65. Eli Lilly Business Overview Table 66. Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Eli Lilly Psoriatic Arthritis Therapeutics Drug Product Portfolio Table 68. Eli Lilly Recent Development Table 69. Pfizer Company Information Table 70. Pfizer Business Overview Table 71. Pfizer Psoriatic Arthritis Therapeutics Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Pfizer Psoriatic Arthritis Therapeutics Drug Product Portfolio Table 73. Pfizer Recent Development Table 74. Amgen Company Information Table 75. Amgen Business Overview Table 76. Amgen Psoriatic Arthritis Therapeutics Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Amgen Psoriatic Arthritis Therapeutics Drug Product Portfolio Table 78. Amgen Recent Development Table 79. AbbVie Company Information Table 80. AbbVie Business Overview Table 81. AbbVie Psoriatic Arthritis Therapeutics Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. AbbVie Psoriatic Arthritis Therapeutics Drug Product Portfolio Table 83. AbbVie Recent Development Table 84. UCB Company Information Table 85. UCB Business Overview Table 86. UCB Psoriatic Arthritis Therapeutics Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. UCB Psoriatic Arthritis Therapeutics Drug Product Portfolio Table 88. UCB Recent Development Table 89. Janssen Biotech Company Information Table 90. Janssen Biotech Business Overview Table 91. Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Janssen Biotech Psoriatic Arthritis Therapeutics Drug Product Portfolio Table 93. Janssen Biotech Recent Development Table 94. CELGENE CORPORATION Company Information Table 95. CELGENE CORPORATION Business Overview Table 96. CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Product Portfolio Table 98. CELGENE CORPORATION Recent Development Table 99. Bristol-Myers Squibb Company Information Table 100. Bristol-Myers Squibb Business Overview Table 101. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Product Portfolio Table 103. Bristol-Myers Squibb Recent Development Table 104. Biogen Company Information Table 105. Biogen Business Overview Table 106. Biogen Psoriatic Arthritis Therapeutics Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Biogen Psoriatic Arthritis Therapeutics Drug Product Portfolio Table 108. Biogen Recent Development Table 109. North America Psoriatic Arthritis Therapeutics Drug Revenue by Type (2021-2026) & (US$ Million) Table 110. North America Psoriatic Arthritis Therapeutics Drug Revenue by Type (2027-2032) & (US$ Million) Table 111. North America Psoriatic Arthritis Therapeutics Drug Sales by Type (2021-2026) & (W Units) Table 112. North America Psoriatic Arthritis Therapeutics Drug Sales by Type (2027-2032) & (W Units) Table 113. North America Psoriatic Arthritis Therapeutics Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 114. North America Psoriatic Arthritis Therapeutics Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 115. North America Psoriatic Arthritis Therapeutics Drug Revenue by Application (2021-2026) & (US$ Million) Table 116. North America Psoriatic Arthritis Therapeutics Drug Revenue by Application (2027-2032) & (US$ Million) Table 117. North America Psoriatic Arthritis Therapeutics Drug Sales by Application (2021-2026) & (W Units) Table 118. North America Psoriatic Arthritis Therapeutics Drug Sales by Application (2027-2032) & (W Units) Table 119. North America Psoriatic Arthritis Therapeutics Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 120. North America Psoriatic Arthritis Therapeutics Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 121. North America Psoriatic Arthritis Therapeutics Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. North America Psoriatic Arthritis Therapeutics Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. North America Psoriatic Arthritis Therapeutics Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. North America Psoriatic Arthritis Therapeutics Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 125. North America Psoriatic Arthritis Therapeutics Drug Sales by Country (2021-2026) & (W Units) Table 126. North America Psoriatic Arthritis Therapeutics Drug Sales by Country (2027-2032) & (W Units) Table 127. North America Psoriatic Arthritis Therapeutics Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 128. North America Psoriatic Arthritis Therapeutics Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 129. United States Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Table 130. Canada Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Table 131. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Type (2021-2026) & (US$ Million) Table 132. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Type (2027-2032) & (US$ Million) Table 133. Europe Psoriatic Arthritis Therapeutics Drug Sales by Type (2021-2026) & (W Units) Table 134. Europe Psoriatic Arthritis Therapeutics Drug Sales by Type (2027-2032) & (W Units) Table 135. Europe Psoriatic Arthritis Therapeutics Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 136. Europe Psoriatic Arthritis Therapeutics Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 137. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Application (2021-2026) & (US$ Million) Table 138. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Application (2027-2032) & (US$ Million) Table 139. Europe Psoriatic Arthritis Therapeutics Drug Sales by Application (2021-2026) & (W Units) Table 140. Europe Psoriatic Arthritis Therapeutics Drug Sales by Application (2027-2032) & (W Units) Table 141. Europe Psoriatic Arthritis Therapeutics Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 142. Europe Psoriatic Arthritis Therapeutics Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 143. Europe Psoriatic Arthritis Therapeutics Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Europe Psoriatic Arthritis Therapeutics Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. Europe Psoriatic Arthritis Therapeutics Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 147. Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2021-2026) & (W Units) Table 148. Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2027-2032) & (W Units) Table 149. Europe Psoriatic Arthritis Therapeutics Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 150. Europe Psoriatic Arthritis Therapeutics Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 151. Germany Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Table 152. France Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Table 153. U.K. Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Table 154. Italy Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Table 155. Netherlands Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Table 156. China Psoriatic Arthritis Therapeutics Drug Revenue by Type (2021-2026) & (US$ Million) Table 157. China Psoriatic Arthritis Therapeutics Drug Revenue by Type (2027-2032) & (US$ Million) Table 158. China Psoriatic Arthritis Therapeutics Drug Sales by Type (2021-2026) & (W Units) Table 159. China Psoriatic Arthritis Therapeutics Drug Sales by Type (2027-2032) & (W Units) Table 160. China Psoriatic Arthritis Therapeutics Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 161. China Psoriatic Arthritis Therapeutics Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 162. China Psoriatic Arthritis Therapeutics Drug Revenue by Application (2021-2026) & (US$ Million) Table 163. China Psoriatic Arthritis Therapeutics Drug Revenue by Application (2027-2032) & (US$ Million) Table 164. China Psoriatic Arthritis Therapeutics Drug Sales by Application (2021-2026) & (W Units) Table 165. China Psoriatic Arthritis Therapeutics Drug Sales by Application (2027-2032) & (W Units) Table 166. China Psoriatic Arthritis Therapeutics Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 167. China Psoriatic Arthritis Therapeutics Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 168. Asia Psoriatic Arthritis Therapeutics Drug Revenue by Type (2021-2026) & (US$ Million) Table 169. Asia Psoriatic Arthritis Therapeutics Drug Revenue by Type (2027-2032) & (US$ Million) Table 170. Asia Psoriatic Arthritis Therapeutics Drug Sales by Type (2021-2026) & (W Units) Table 171. Asia Psoriatic Arthritis Therapeutics Drug Sales by Type (2027-2032) & (W Units) Table 172. Asia Psoriatic Arthritis Therapeutics Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 173. Asia Psoriatic Arthritis Therapeutics Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 174. Asia Psoriatic Arthritis Therapeutics Drug Revenue by Application (2021-2026) & (US$ Million) Table 175. Asia Psoriatic Arthritis Therapeutics Drug Revenue by Application (2027-2032) & (US$ Million) Table 176. Asia Psoriatic Arthritis Therapeutics Drug Sales by Application (2021-2026) & (W Units) Table 177. Asia Psoriatic Arthritis Therapeutics Drug Sales by Application (2027-2032) & (W Units) Table 178. Asia Psoriatic Arthritis Therapeutics Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 179. Asia Psoriatic Arthritis Therapeutics Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 180. Asia Psoriatic Arthritis Therapeutics Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Asia Psoriatic Arthritis Therapeutics Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. Asia Psoriatic Arthritis Therapeutics Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. Asia Psoriatic Arthritis Therapeutics Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 184. Asia Psoriatic Arthritis Therapeutics Drug Sales by Country (2021-2026) & (W Units) Table 185. Asia Psoriatic Arthritis Therapeutics Drug Sales by Country (2027-2032) & (W Units) Table 186. Asia Psoriatic Arthritis Therapeutics Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 187. Asia Psoriatic Arthritis Therapeutics Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 188. Japan Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Table 189. South Korea Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Table 190. India Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Table 191. Australia Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Table 192. China Taiwan Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Table 193. Southeast Asia Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Table 194. SAMEA Psoriatic Arthritis Therapeutics Drug Revenue by Type (2021-2026) & (US$ Million) Table 195. SAMEA Psoriatic Arthritis Therapeutics Drug Revenue by Type (2027-2032) & (US$ Million) Table 196. SAMEA Psoriatic Arthritis Therapeutics Drug Sales by Type (2021-2026) & (W Units) Table 197. SAMEA Psoriatic Arthritis Therapeutics Drug Sales by Type (2027-2032) & (W Units) Table 198. SAMEA Psoriatic Arthritis Therapeutics Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 199. SAMEA Psoriatic Arthritis Therapeutics Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 200. SAMEA Psoriatic Arthritis Therapeutics Drug Revenue by Application (2021-2026) & (US$ Million) Table 201. SAMEA Psoriatic Arthritis Therapeutics Drug Revenue by Application (2027-2032) & (US$ Million) Table 202. SAMEA Psoriatic Arthritis Therapeutics Drug Sales by Application (2021-2026) & (W Units) Table 203. SAMEA Psoriatic Arthritis Therapeutics Drug Sales by Application (2027-2032) & (W Units) Table 204. SAMEA Psoriatic Arthritis Therapeutics Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 205. SAMEA Psoriatic Arthritis Therapeutics Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 206. SAMEA Psoriatic Arthritis Therapeutics Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. SAMEA Psoriatic Arthritis Therapeutics Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. SAMEA Psoriatic Arthritis Therapeutics Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. SAMEA Psoriatic Arthritis Therapeutics Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 210. SAMEA Psoriatic Arthritis Therapeutics Drug Sales by Country (2021-2026) & (W Units) Table 211. SAMEA Psoriatic Arthritis Therapeutics Drug Sales by Country (2027-2032) & (W Units) Table 212. SAMEA Psoriatic Arthritis Therapeutics Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 213. SAMEA Psoriatic Arthritis Therapeutics Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 214. Brazil Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Table 215. Argentina Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Table 216. Chile Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Table 217. Colombia Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Table 218. Peru Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Table 219. Saudi Arabia Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Table 220. Israel Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Table 221. UAE Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Table 222. Turkey Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Table 223. Iran Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Table 224. Egypt Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Table 225. Key Raw Materials Table 226. Raw Materials Key Suppliers Table 227. Psoriatic Arthritis Therapeutics Drug Distributors List Table 228. Psoriatic Arthritis Therapeutics Drug Customers List Table 229. Research Programs/Design for This Report Table 230. Authors List of This Report Table 231. Secondary Sources Table 232. Primary Sources List of Figures Figure 1. Psoriatic Arthritis Therapeutics Drug Image Figure 2. Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Psoriatic Arthritis Therapeutics Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Interleukin Inhibitors Image Figure 5. NF Inhibitors Image Figure 6. PDE4 Inhibitors Image Figure 7. Others Image Figure 8. Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Psoriatic Arthritis Therapeutics Drug Market Size Share 2021 VS 2025 VS 2032 Figure 10. Retail Pharmacies Image Figure 11. Online Pharmacies Image Figure 12. Hospital Pharmacies Image Figure 13. Global Psoriatic Arthritis Therapeutics Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Psoriatic Arthritis Therapeutics Drug Revenue (2021-2032) & (US$ Million) Figure 15. Global Psoriatic Arthritis Therapeutics Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region (2021-2032) Figure 18. Global Psoriatic Arthritis Therapeutics Drug Sales (2021-2032) & (W Units) Figure 19. Global Psoriatic Arthritis Therapeutics Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 20. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Psoriatic Arthritis Therapeutics Drug Sales YoY (2021-2032) & (W Units) Figure 22. Europe Psoriatic Arthritis Therapeutics Drug Sales YoY (2021-2032) & (W Units) Figure 23. China Psoriatic Arthritis Therapeutics Drug Sales YoY (2021-2032) & (W Units) Figure 24. Asia (Excluding China) Psoriatic Arthritis Therapeutics Drug Sales YoY (2021-2032) & (W Units) Figure 25. South America, Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales YoY (2021-2032) & (W Units) Figure 26. Global Psoriatic Arthritis Therapeutics Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Psoriatic Arthritis Therapeutics Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2021-2032) Figure 32. Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 33. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2021-2032) Figure 35. Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2021-2032) Figure 38. Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 39. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2021-2032) Figure 41. North America Psoriatic Arthritis Therapeutics Drug Revenue Share by Type (2021-2032) Figure 42. North America Psoriatic Arthritis Therapeutics Drug Sales Share by Type (2021-2032) Figure 43. North America Psoriatic Arthritis Therapeutics Drug Revenue Share by Application (2021-2032) Figure 44. North America Psoriatic Arthritis Therapeutics Drug Sales Share by Application (2021-2032) Figure 45. North America Psoriatic Arthritis Therapeutics Drug Revenue Share by Country (2021-2032) Figure 46. North America Psoriatic Arthritis Therapeutics Drug Sales Share by Country (2021-2032) Figure 47. Europe Psoriatic Arthritis Therapeutics Drug Revenue Share by Type (2021-2032) Figure 48. Europe Psoriatic Arthritis Therapeutics Drug Sales Share by Type (2021-2032) Figure 49. Europe Psoriatic Arthritis Therapeutics Drug Revenue Share by Application (2021-2032) Figure 50. Europe Psoriatic Arthritis Therapeutics Drug Sales Share by Application (2021-2032) Figure 51. Europe Psoriatic Arthritis Therapeutics Drug Revenue Share by Country (2021-2032) Figure 52. Europe Psoriatic Arthritis Therapeutics Drug Sales Share by Country (2021-2032) Figure 53. China Psoriatic Arthritis Therapeutics Drug Revenue Share by Type (2021-2032) Figure 54. China Psoriatic Arthritis Therapeutics Drug Sales Share by Type (2021-2032) Figure 55. China Psoriatic Arthritis Therapeutics Drug Revenue Share by Application (2021-2032) Figure 56. China Psoriatic Arthritis Therapeutics Drug Sales Share by Application (2021-2032) Figure 57. Asia Psoriatic Arthritis Therapeutics Drug Revenue Share by Type (2021-2032) Figure 58. Asia Psoriatic Arthritis Therapeutics Drug Sales Share by Type (2021-2032) Figure 59. Asia Psoriatic Arthritis Therapeutics Drug Revenue Share by Application (2021-2032) Figure 60. Asia Psoriatic Arthritis Therapeutics Drug Sales Share by Application (2021-2032) Figure 61. Asia Psoriatic Arthritis Therapeutics Drug Revenue Share by Country (2021-2032) Figure 62. Asia Psoriatic Arthritis Therapeutics Drug Sales Share by Country (2021-2032) Figure 63. SAMEA Psoriatic Arthritis Therapeutics Drug Revenue Share by Type (2021-2032) Figure 64. SAMEA Psoriatic Arthritis Therapeutics Drug Sales Share by Type (2021-2032) Figure 65. SAMEA Psoriatic Arthritis Therapeutics Drug Revenue Share by Application (2021-2032) Figure 66. SAMEA Psoriatic Arthritis Therapeutics Drug Sales Share by Application (2021-2032) Figure 67. SAMEA Psoriatic Arthritis Therapeutics Drug Revenue Share by Country (2021-2032) Figure 68. SAMEA Psoriatic Arthritis Therapeutics Drug Sales Share by Country (2021-2032) Figure 69. Psoriatic Arthritis Therapeutics Drug Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Psoriatic Arthritis Therapeutics Drug Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Interleukin Inhibitors
  • NF Inhibitors
  • PDE4 Inhibitors
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Novartis
  • Eli Lilly
  • Pfizer
  • Amgen
  • AbbVie
  • UCB
  • Janssen Biotech
  • CELGENE CORPORATION
  • Bristol-Myers Squibb
  • Biogen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Psoriatic Arthritis Therapeutics Drug Market by Type
  3. 1.2.1 Global Psoriatic Arthritis Therapeutics Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Interleukin Inhibitors
  5. 1.2.3 NF Inhibitors
  6. 1.2.4 PDE4 Inhibitors
  7. 1.2.5 Others
  8. 1.3 Psoriatic Arthritis Therapeutics Drug Market by Application
  9. 1.3.1 Global Psoriatic Arthritis Therapeutics Drug Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Retail Pharmacies
  11. 1.3.3 Online Pharmacies
  12. 1.3.4 Hospital Pharmacies
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Psoriatic Arthritis Therapeutics Drug Market Dynamics
  1. 2.1 Psoriatic Arthritis Therapeutics Drug Industry Trends
  2. 2.2 Psoriatic Arthritis Therapeutics Drug Industry Drivers
  3. 2.3 Psoriatic Arthritis Therapeutics Drug Industry Opportunities and Challenges
  4. 2.4 Psoriatic Arthritis Therapeutics Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Psoriatic Arthritis Therapeutics Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region
  3. 3.2.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Psoriatic Arthritis Therapeutics Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Psoriatic Arthritis Therapeutics Drug Sales by Region
  9. 3.4.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Psoriatic Arthritis Therapeutics Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Psoriatic Arthritis Therapeutics Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturers
  2. 4.1.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Psoriatic Arthritis Therapeutics Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Psoriatic Arthritis Therapeutics Drug Sales by Manufacturers
  6. 4.2.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Psoriatic Arthritis Therapeutics Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Psoriatic Arthritis Therapeutics Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Psoriatic Arthritis Therapeutics Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Psoriatic Arthritis Therapeutics Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Psoriatic Arthritis Therapeutics Drug Manufacturers, Product Type & Application
  13. 4.7 Global Psoriatic Arthritis Therapeutics Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Psoriatic Arthritis Therapeutics Drug Market CR5 and HHI
  16. 4.8.2 2025 Psoriatic Arthritis Therapeutics Drug Tier 1, Tier 2, and Tier 3
5 Psoriatic Arthritis Therapeutics Drug Market by Type
  1. 5.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Type
  2. 5.1.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Psoriatic Arthritis Therapeutics Drug Sales by Type
  6. 5.2.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Psoriatic Arthritis Therapeutics Drug Price by Type
6 Psoriatic Arthritis Therapeutics Drug Market by Application
  1. 6.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Application
  2. 6.1.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Psoriatic Arthritis Therapeutics Drug Sales by Application
  6. 6.2.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Psoriatic Arthritis Therapeutics Drug Price by Application
7 Company Profiles
  1. 7.1 Novartis
  2. 7.1.1 Novartis Company Information
  3. 7.1.2 Novartis Business Overview
  4. 7.1.3 Novartis Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis Psoriatic Arthritis Therapeutics Drug Product Portfolio
  6. 7.1.5 Novartis Recent Developments
  7. 7.2 Eli Lilly
  8. 7.2.1 Eli Lilly Company Information
  9. 7.2.2 Eli Lilly Business Overview
  10. 7.2.3 Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Eli Lilly Psoriatic Arthritis Therapeutics Drug Product Portfolio
  12. 7.2.5 Eli Lilly Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Psoriatic Arthritis Therapeutics Drug Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 Amgen
  20. 7.4.1 Amgen Company Information
  21. 7.4.2 Amgen Business Overview
  22. 7.4.3 Amgen Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Amgen Psoriatic Arthritis Therapeutics Drug Product Portfolio
  24. 7.4.5 Amgen Recent Developments
  25. 7.5 AbbVie
  26. 7.5.1 AbbVie Company Information
  27. 7.5.2 AbbVie Business Overview
  28. 7.5.3 AbbVie Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 AbbVie Psoriatic Arthritis Therapeutics Drug Product Portfolio
  30. 7.5.5 AbbVie Recent Developments
  31. 7.6 UCB
  32. 7.6.1 UCB Company Information
  33. 7.6.2 UCB Business Overview
  34. 7.6.3 UCB Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 UCB Psoriatic Arthritis Therapeutics Drug Product Portfolio
  36. 7.6.5 UCB Recent Developments
  37. 7.7 Janssen Biotech
  38. 7.7.1 Janssen Biotech Company Information
  39. 7.7.2 Janssen Biotech Business Overview
  40. 7.7.3 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Product Portfolio
  42. 7.7.5 Janssen Biotech Recent Developments
  43. 7.8 CELGENE CORPORATION
  44. 7.8.1 CELGENE CORPORATION Company Information
  45. 7.8.2 CELGENE CORPORATION Business Overview
  46. 7.8.3 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Product Portfolio
  48. 7.8.5 CELGENE CORPORATION Recent Developments
  49. 7.9 Bristol-Myers Squibb
  50. 7.9.1 Bristol-Myers Squibb Company Information
  51. 7.9.2 Bristol-Myers Squibb Business Overview
  52. 7.9.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Product Portfolio
  54. 7.9.5 Bristol-Myers Squibb Recent Developments
  55. 7.10 Biogen
  56. 7.10.1 Biogen Company Information
  57. 7.10.2 Biogen Business Overview
  58. 7.10.3 Biogen Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Biogen Psoriatic Arthritis Therapeutics Drug Product Portfolio
  60. 7.10.5 Biogen Recent Developments
8 North America
  1. 8.1 North America Psoriatic Arthritis Therapeutics Drug Market Size by Type
  2. 8.1.1 North America Psoriatic Arthritis Therapeutics Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Psoriatic Arthritis Therapeutics Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Psoriatic Arthritis Therapeutics Drug Price by Type (2021-2032)
  5. 8.2 North America Psoriatic Arthritis Therapeutics Drug Market Size by Application
  6. 8.2.1 North America Psoriatic Arthritis Therapeutics Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Psoriatic Arthritis Therapeutics Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Psoriatic Arthritis Therapeutics Drug Price by Application (2021-2032)
  9. 8.3 North America Psoriatic Arthritis Therapeutics Drug Market Size by Country
  10. 8.3.1 North America Psoriatic Arthritis Therapeutics Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Psoriatic Arthritis Therapeutics Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Psoriatic Arthritis Therapeutics Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Psoriatic Arthritis Therapeutics Drug Market Size by Type
  2. 9.1.1 Europe Psoriatic Arthritis Therapeutics Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Psoriatic Arthritis Therapeutics Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Psoriatic Arthritis Therapeutics Drug Price by Type (2021-2032)
  5. 9.2 Europe Psoriatic Arthritis Therapeutics Drug Market Size by Application
  6. 9.2.1 Europe Psoriatic Arthritis Therapeutics Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Psoriatic Arthritis Therapeutics Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Psoriatic Arthritis Therapeutics Drug Price by Application (2021-2032)
  9. 9.3 Europe Psoriatic Arthritis Therapeutics Drug Market Size by Country
  10. 9.3.1 Europe Psoriatic Arthritis Therapeutics Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Psoriatic Arthritis Therapeutics Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Psoriatic Arthritis Therapeutics Drug Market Size by Type
  2. 10.1.1 China Psoriatic Arthritis Therapeutics Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Psoriatic Arthritis Therapeutics Drug Sales by Type (2021-2032)
  4. 10.1.3 China Psoriatic Arthritis Therapeutics Drug Price by Type (2021-2032)
  5. 10.2 China Psoriatic Arthritis Therapeutics Drug Market Size by Application
  6. 10.2.1 China Psoriatic Arthritis Therapeutics Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Psoriatic Arthritis Therapeutics Drug Sales by Application (2021-2032)
  8. 10.2.3 China Psoriatic Arthritis Therapeutics Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Psoriatic Arthritis Therapeutics Drug Market Size by Type
  2. 11.1.1 Asia Psoriatic Arthritis Therapeutics Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Psoriatic Arthritis Therapeutics Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Psoriatic Arthritis Therapeutics Drug Price by Type (2021-2032)
  5. 11.2 Asia Psoriatic Arthritis Therapeutics Drug Market Size by Application
  6. 11.2.1 Asia Psoriatic Arthritis Therapeutics Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Psoriatic Arthritis Therapeutics Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Psoriatic Arthritis Therapeutics Drug Price by Application (2021-2032)
  9. 11.3 Asia Psoriatic Arthritis Therapeutics Drug Market Size by Country
  10. 11.3.1 Asia Psoriatic Arthritis Therapeutics Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Psoriatic Arthritis Therapeutics Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Psoriatic Arthritis Therapeutics Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Psoriatic Arthritis Therapeutics Drug Market Size by Type
  2. 12.1.1 SAMEA Psoriatic Arthritis Therapeutics Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Psoriatic Arthritis Therapeutics Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Psoriatic Arthritis Therapeutics Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Psoriatic Arthritis Therapeutics Drug Market Size by Application
  6. 12.2.1 SAMEA Psoriatic Arthritis Therapeutics Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Psoriatic Arthritis Therapeutics Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Psoriatic Arthritis Therapeutics Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Psoriatic Arthritis Therapeutics Drug Market Size by Country
  10. 12.3.1 SAMEA Psoriatic Arthritis Therapeutics Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Psoriatic Arthritis Therapeutics Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Psoriatic Arthritis Therapeutics Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Psoriatic Arthritis Therapeutics Drug Value Chain Analysis
  2. 13.1.1 Psoriatic Arthritis Therapeutics Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Psoriatic Arthritis Therapeutics Drug Production Mode & Process
  6. 13.2 Psoriatic Arthritis Therapeutics Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Psoriatic Arthritis Therapeutics Drug Distributors
  9. 13.2.3 Psoriatic Arthritis Therapeutics Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst